NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Oct. 4, 2024-- Johnson & Johnson (NYSE: JNJ) will participate in the Guggenheim Global Healthcare Conference on Tuesday, November 12^th, at theInterContinental Boston in Boston, MA.Biljana Naumovic, President, Solid Tumor, U.S. Oncology and Mark Wildgust, Vice President, Global Medical Affairs Oncology, will represent the Company in a session scheduled at 10:30 a.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48 hours after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241004735017/en/

Media contact:
media-relations@its.jnj.com

Investor contact:
investor-relations@its.jnj.com

Source: Johnson & Johnson